Role of glucose metabolism in the recovery of postischemic LV mechanical function: Effects of insulin and other metabolic modulators

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 6, 2008, Pages

  Gandhi, Manoj ^a   Finegan, Barry A ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Contractile function; Ischemia reperfusion; Proton production; Rat hearts

Indexed keywords

CYCLOHEXYLADENOSINE; DICHLOROACETIC ACID; GLUCOSE; INSULIN; OXFENICINE; PALMITIC ACID; PROTON; 4-HYDROXYPHENYLGLYCINE; ADENOSINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GLYCINE; N(6) CYCLOHEXYLADENOSINE; N(6)-CYCLOHEXYLADENOSINE;

ANIMAL TISSUE; ARTICLE; CONVALESCENCE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECT; ENERGY METABOLISM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; IN VITRO STUDY; METABOLISM; PERFUSION; PH; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; TIME;

ADENOSINE; ANIMALS; DICHLOROACETATE; ENERGY METABOLISM; ENZYME INHIBITORS; GLUCOSE; GLYCINE; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; INSULIN; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PALMITIC ACID; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 49249139941     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00942.2007     Document Type: Article

References (49)

1. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion. Circ Res 52: 515-526, 1983.
2. Apstein CS, Taegtmeyer H. Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial. Circulation 96: 1074-1077, 1997.
3. Bergstra A, Svilaas T, van den Heuvel AF, van der Horst IC, Zijlstra F. Glucose-insulin-potassium infusion in acute myocardial infarction: a hemodynamic study. Am Heart J 151: 345-351, 2006.
4. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999.
5. Bothe W, Olschewski M, Beyersdorf F, Doenst T. Glucose-insulinpotassium in cardiac surgery: a meta-analysis. Ann Thorac Surg 78: 1650-1657, 2004.
6. Brownsey RW, Boone AN, Allard MF. Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms. Cardiovasc Res 34: 3-24, 1997.
7. 2+ overload and left ventricular mechanical dysfunction. J Cardiovasc Electrophysiol 17 Suppl 1: S141-S148, 2006.
8. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98: 2227-2234, 1998.
9. Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg 67: 1682-1688, 1999.
10. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130: 1144, 2005.
11. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo- controlled trials. Circulation 96: 1152-1156, 1997.
12. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol Endocrinol Metab 264: E308-E315, 1993.
13. Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908, 1993.
14. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia. Br J Pharmacol 118: 355-363, 1996.
15. Fischer-Rasokat U, Doenst T. Insulin-induced improvement of postische mic recovery is abolished by inhibition of protein kinase C in rat heart. J Thorac Cardiovasc Surg 126: 1806-1812, 2003.
16. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5 -AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 99: 61-68, 2006.
17. Fraser H, Lopaschuk GD, Clanachan AS. Assessment of glycogen turnover in aerobic, ischemic, and reperfused working rat hearts. Am J Physiol Heart Circ Physiol 275: H1533-H1541, 1998.
18. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146: 233-243, 2007.
19. Hachida M, Ookado A, Nonoyama M, Koyanagi H. Effect of HTK solution for myocardial preservation. J Cardiovasc Surg (Torino) 37: 269-274, 1996.
20. Hafstad AD, Khalid AM, How OJ, Larsen TS, Aasum E. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol Endocrinol Metab 292: E1288-E1294, 2007.
21. Janiger JL, Cheng JW. Glucose-insulin-potassium solution for acute myocardial infarction. Ann Pharmacother 36: 1080-1084, 2002.
22. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70S6 kinase cell-survival signaling. Circ Res 89: 1191-1198, 2001.
23. Korb H, Hoeft A, Hunneman DH, Schraeder R, Wolpers HG, Wober W, Hellige G. Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine]. Naunyn Schmiedebergs Arch Pharmacol 327: 70-74, 1984.
24. Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117: 1018-1027, 2008.
25. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 79: 940-948, 1996.
26. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 39: 718-725, 2002.
27. Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, Finegan BA. Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128: 61-67, 1994.
28. Lopaschuk GD, Rebeyka IM, Allard MF. Metabolic modulation: a means to mend a broken heart. Circulation 105: 140-142, 2002.
29. Marina Prendes MG, Garcia JV, Testoni G, Fernandez MA, Perazzo JC, Savino EA, Varela A. Influence of fasting on the effects of dimethylamiloride and oxfenicine on ischaemic-reperfused rat hearts. Arch Physiol Biochem 112: 31-36, 2006.
30. McNulty PH. Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease. Am J Physiol Heart Circ Physiol 278: H741-H747, 2000.
31. McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol Heart Circ Physiol 259: H1079-H1085, 1990.
32. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 293: 437-446, 2005.
33. Ofir M, Arad M, Porat E, Freimark D, Chepurko Y, Vidne BA, Seidman CE, Seidman JG, Kemp BE, Hochhauser E. Increased glycogen stores due to γ-AMPK overexpression protects against ischemia and reperfusion damage. Biochem Pharmacol 75: 1482-1491, 2008.
34. Omar MA, Fraser H, Clanachan AS. Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete working rat hearts. Am J Physiol Heart Circ Physiol 294: H1266-H1273, 2008.
35. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
36. Sauvage M, Maziere P, Fathallah H, Giraud F. Insulin stimulates NHE1 activity by sequential activation of phosphatidylinositol 3-kinase and protein kinase C in human erythrocytes. Eur J Biochem 267: 955-962, 2000.
37. Schipke JD, Friebe R, Gams E. Forty years of glucose-insulin- potassium (GIK) in cardiac surgery: a review of randomized, controlled trials. Eur J Cardiothorac Surg 29: 479-485, 2006.
38. Schmidt HD, Koch M. Influence of perfusate calcium concentration on the inotropic insulin effect in isolated guinea pig and rat hearts. Basic Res Cardiol 97: 305-311, 2002.
39. Shikama H, Noshiro O, Ohta A, Ohata I. Effects of acylcarnitine-transferase inhibitors on adenine nucleotide metabolism and ischemic tissue injury in isolated perfused rat heart. Jpn Heart J 29: 723-734, 1988.
40. Sodi-Pallares D, Ponce de LJ, Bisteni A, Medrano GA. Potassium, glucose, and insulin in myocardial infarction. Lancet 1: 1315-1316, 1969.
41. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129, 2005.
42. Su H, Sun X, Ma H, Zhang HF, Yu QJ, Huang C, Wang XM, Luan RH, Jia GL, Wang HC, Gao F. Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK. Am J Physiol Endocrinol Metab 293: E629-E635, 2007.
43. + decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem 7: 852-862, 2002.
44. Suzuki K, Murtuza B, Smolenski RT, Suzuki N, Yacoub MH. Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts. Transplantation 73: 1398-1402, 2002.
45. Tada K, Nagao K, Tanjoh K, Hayashi N. Prognostic value of blood glucose in patients with cardiogenic shock. Circ J 70: 1064-1069, 2006.
46. Tracey WR, Treadway JL, Magee WP, Sutt JC, McPherson RK, Levy CB, Wilder DE, Yu LJ, Chen Y, Shanker RM, Mutchler AK, Smith AH, Flynn DM, Knight DR. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol 286: H1177-H1184, 2004.
47. Wang P, Lloyd SG, Chatham JC. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation 111: 2066-2072, 2005.
48. Wolfe CL, Sievers RE, Visseren FL, Donnelly TJ. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881-892, 1993.
49. Yu J, Zhang HF, Wu F, Li QX, Ma H, Guo WY, Wang HC, Gao F. Insulin improves cardiomyocyte contractile function through enhancement of SERCA2a activity in simulated ischemia/reperfusion. Acta Pharmacol Sin 27: 919-926, 2006.